Zoek binnen de website

home / news & insights /

Amsterdam, 31 januari 2020

Collectieve Actions in the Netherlands 2019

By Damiën Berkhout

Damiën Berkhout provides an anlysis of the collective action developments in the Netherlands in the year 2019 for the Corporate Litigation Association. He also provides a forward look, and discusses the expected value of 2019 case law for the new WAMCA regime.

The chronicle has been published in the Geschiften vanwege de Vereniging Corporate Litigation 2019-2020 (Serie Van der Heijden Instituut nr. 165), Deventer: Wolters Kluwer 2020. You can read the analysis here (in Dutch)

Damiën Berkhout

Partner, dispute resolution expert

Contact

Meer publicaties

Collective action on excessive pricing of pharmaceuticals moves on to merits phase

5 september 2024 - News

The Amsterdam District Court ruled that the representative organization Stichting Farma Ter Verantwoording is admissible in its collective action against pharmaceutical giant AbbVie. The case now moves on to the merits phase, in which the court will assess whether Abbvie abused its dominant position and violated human rights by charging excessive prices for its Humira medicine.

Lees meer

Amsterdam Court of Appeal provides key decision regarding WAMCA admissibility requirements

28 augustus 2024 - Insights

The Amsterdam Court of Appeal has provided guidance for future Dutch mass tort cases in its decision in the matter between The Privacy Collective and Oracle and Salesforce.

Lees meer

Recente ontwikkelingen vernietiging bij aandelenkoop

12 augustus 2024 - Publications

Lindenbaum-partner Guido Vergouwen heeft een annotatie geschreven voor de JIN over problemen bij vernietiging van een aandelenkoop naar aanleiding van het Hoge Raad-arrest Rookie/ABC Hekwerk c.s.

Lees meer